Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") (KRYS)

Q: What does CUSIP 501147102 represent in this 13F holders report?

CUSIP 501147102 is the security identifier for KRYS - Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") used to aggregate holder disclosures.

Q: How many institutions held KRYS - Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") in Q2 2019?

75 institutional investors reported KRYS - Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") for Q2 2019. Use the holders table for investor-level position and value details.

CUSIP: 501147102

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock, $0.00001 par value ("Common Stock")
Shares outstanding: 29,463,330
Total 13F shares: 9,765,134
Share change: +3,112,524
Total reported value: $393,197,420
Price per share: $40.27
Number of holders: 75
Value change: +$130,560,730
Number of buys: 55
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 501147102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KRYS - Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.2%	1,235,400	$40,645,000	—	31 Mar 2019	13F
FRAZIER MANAGEMENT LLC	13F	Company	3%	875,000	$28,788,000	—	31 Mar 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	2.7%	784,674	$25,816,000	—	31 Mar 2019	13F
GREAT POINT PARTNERS LLC	13F	Company	1.7%	492,100	$16,190,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	1.2%	353,470	$11,629,000	—	31 Mar 2019	13F
Redmile Group, LLC	13F	Company	1.1%	324,500	$10,676,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	1.1%	322,874	$10,623,000	—	31 Mar 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1%	304,120	$10,006,000	—	31 Mar 2019	13F
Artal Group S.A.	13F	Company	1%	300,000	$9,870,000	—	31 Mar 2019	13F
Knoll Capital Management, LLC	13F	Company	0.71%	209,986	$6,909,000	—	31 Mar 2019	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.62%	181,625	$5,975,000	—	31 Mar 2019	13F
CWM, LLC	13F	Company	0.21%	62,112	$4,224,000	—	31 Mar 2019	13F
Nicholas Investment Partners, LP	13F	Company	0.38%	111,225	$3,659,000	—	31 Mar 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	89,155	$2,933,000	—	31 Mar 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.29%	84,084	$2,766,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.24%	71,698	$2,358,000	—	31 Mar 2019	13F
S Squared Technology, LLC	13F	Company	0.23%	68,900	$2,267,000	—	31 Mar 2019	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.22%	66,206	$2,178,000	—	31 Mar 2019	13F
Endurant Capital Management LP	13F	Company	0.21%	61,155	$2,012,000	—	31 Mar 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.2%	59,210	$1,948,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	0.19%	55,197	$1,816,000	—	31 Mar 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	45,493	$1,497,000	—	31 Mar 2019	13F
Laurion Capital Management LP	13F	Company	0.13%	37,383	$1,230,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.12%	35,986	$1,184,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.12%	35,255	$1,160,000	—	31 Mar 2019	13F
P.A.W. CAPITAL CORP	13F	Company	0.12%	35,000	$1,152,000	—	31 Mar 2019	13F
ALPS ADVISORS INC	13F	Company	0.12%	34,851	$1,147,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	31,284	$1,029,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.1%	30,800	$1,013,000	—	31 Mar 2019	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.1%	30,544	$1,005,000	—	31 Mar 2019	13F
Informed Momentum Co LLC	13F	Company	0.08%	22,821	$751,000	—	31 Mar 2019	13F
CITIGROUP INC	13F	Company	0.08%	22,114	$728,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.07%	21,424	$705,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.07%	20,867	$687,000	—	31 Mar 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.07%	19,737	$649,000	—	31 Mar 2019	13F
Tibra Equities Europe Ltd	13F	Company	0.07%	19,472	$641,000	—	31 Mar 2019	13F
RITHOLTZ WEALTH MANAGEMENT	13F	Company	0.07%	19,409	$639,000	—	31 Mar 2019	13F
ExodusPoint Capital Management, LP	13F	Company	0.06%	17,648	$581,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	15,374	$505,000	—	31 Mar 2019	13F
BB&T SECURITIES, LLC	13F	Company	0.04%	11,000	$361,000	—	31 Mar 2019	13F
Neuberger Berman Group LLC	13F	Company	0.03%	9,500	$313,000	—	31 Mar 2019	13F
BlueCrest Capital Management Ltd	13F	Company	0.03%	9,280	$305,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	9,175	$302,000	—	31 Mar 2019	13F
MYDA Advisors LLC	13F	Company	0.03%	9,000	$296,000	—	31 Mar 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	8,153	$268,000	—	31 Mar 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	8,000	$263,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.02%	7,003	$230,000	—	31 Mar 2019	13F
Squarepoint Ops LLC	13F	Company	0.02%	6,651	$219,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	6,615	$218,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	6,578	$216,000	—	31 Mar 2019	13F

Institutional Holders of Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q2 2019

As of 30 Jun 2019, Krystal Biotech, Inc. (the "Company") - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,765,134 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, FRAZIER MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, and Artal Group S.A.. This page lists 75 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.